Phase I study of amrubicin (AMR) for patients (pts) with previously treated small cell lung cancer (SCLC)

被引：0
|
作者：
Katakami, N.
Hata, A.
Yoshioka, H.
Higashi, Y.
Nishimura, T.
Sakaguchi, S.
Hayashi, M.
Tomii, K.
Naya, R.
Ishihara, K.
机构：
[1] Kobe City Gen Hosp, Kobe, Hyogo, Japan
[2] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18209
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II study of RAD001 (Everolimus) in previously treated small cell lung cancer (SCLC)
    Owonikoko, T. K.
    Stoller, R. G.
    Petro, D.
    Flaugh, R.
    Hershberger, P. A.
    Belani, C. P.
    Argiris, A. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] Phase II study of RAD001 (everolimus) in previously treated small cell lung cancer (SCLC)
    Kotsakis, A. P.
    Tarhini, A.
    Petro, D.
    Flaugh, R.
    Vallabhaneni, G.
    Belani, C. P.
    Friedland, D.
    Argiris, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] A phase II study of combination therapy with liposomal doxorubicin and carboplatin (CBDCA) in patients (pts) with previously untreated small cell lung cancer (SCLC).
    Vorobiof, DA
    Rapoport, BL
    Slabber, CF
    Alberts, AS
    Uys, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 690S - 690S
  • [34] Phase II study of amrubicin (AMR) combined with carboplatin (CBDCA) for refractory relapsed small cell lung cancer (SCLC): North Japan Lung Cancer Group 0802.
    Saito, Ryota
    Inoue, Akira
    Sugawara, Shunichi
    Oizumi, Satoshi
    Maemondo, Makoto
    Okudera, Koichi
    Suzuki, Toshiro
    Usui, Kazuhiro
    Harada, Masao
    Morikawa, Naoto
    Hasegawa, YUkihiro
    Ishimoto, Osamu
    Sakakibara, Tomohiro
    Asahina, Hajime
    Nukiwa, Toshihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Phase II study of amrubicin at a dose of 45 mg/m2 in patients with previously treated small-cell lung cancer
    Asao, Tetsuhiko
    Nokihara, Hiroshi
    Yoh, Kiyotaka
    Niho, Seiji
    Goto, Koichi
    Ohmatsu, Hironobu
    Kubota, Kaoru
    Yamamoto, Noboru
    Sekine, Ikuo
    Kunitoh, Hideo
    Fujiwara, Yutaka
    Ohe, Yuichiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (10) : 941 - 946
  • [36] Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer
    Hotta, K
    Takigawa, N
    Kiura, K
    Tabata, M
    Umemura, S
    Ogino, A
    Uchida, A
    Bessho, A
    Segawa, Y
    Shinkai, T
    Nogami, N
    Harita, S
    Okimoto, N
    Ueoka, H
    Tanimoto, M
    ANTICANCER RESEARCH, 2005, 25 (3C) : 2429 - 2434
  • [37] A phase I study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer
    Inoue, Akira
    Yamazaki, Koichi
    Maemondo, Makoto
    Suzuki, Takuji
    Kimura, Yuichiro
    Kanbe, Mariko
    Isobe, Hiroshi
    Nishimura, Masaharu
    Saijo, Yasuo
    Nukiwa, Toshihiro
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (06) : 551 - 555
  • [38] Phase ll study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer
    Fukuda, M. I.
    Kitazaki, T.
    Nakamura, Y.
    Kinoshita, A.
    Fukuda, M. A.
    Takatani, H.
    Soda, H.
    Soejima, Y.
    Nagashima, S.
    Kohno, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S832 - S832
  • [39] Phase II study of amrubicin (AMR) in patients (pts) with non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy: preliminary results of West Japan Thoracic Oncology Group study (WJTOG0401)
    Mitsuoka, Shigeki
    Kaneda, Hiroyasu
    Hayashi, Hidetoshi
    Sawa, Toshiyuki
    Goto, Isao
    Akita, Kenji
    Saito, Hiroshi
    Shibata, Kazuhiko
    Okamoto, Isamu
    Nakagawa, Kazuhiko
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S449 - S449
  • [40] Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer
    Ohe, Y
    Negoro, S
    Matsui, K
    Nakagawa, K
    Sugiura, T
    Takada, Y
    Nishiwaki, Y
    Yokota, S
    Kawahara, M
    Saijo, N
    Fukuoka, M
    Ariyoshi, Y
    ANNALS OF ONCOLOGY, 2005, 16 (03) : 430 - 436
12345